Reports for NATCO PHARMA (CANADA) INC

Company Name
NATCO PHARMA (CANADA) INC

Shortage reports

Actual shortage:

30 (61%)

Anticipated shortage:

0 (0%)

Avoided shortage:

0 (0%)

Resolved:

19 (39%)

49

Discontinuation Reports

To be discontinued:

0

Discontinued:

0

Reversed:

0

0

1 (2%)

9 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-ESCITALOPRAM 20MG TABLET Resolved 2024-02-02 2024-05-10 218258
NAT-EVEROLIMUS 10MG TABLET Actual shortage 2024-11-01 2024-12-16 241868
NAT-EVEROLIMUS 2.5MG TABLET Actual shortage 2024-04-29 2024-12-16 226575
NAT-EVEROLIMUS 5MG TABLET Actual shortage 2024-11-01 2024-12-16 241865
NAT-GEFITINIB 250MG TABLET Actual shortage 2025-04-04 2025-04-05 254195
NAT-IMATINIB 100MG TABLET Actual shortage 2024-08-30 2024-09-02 236421
NAT-IMATINIB 400MG TABLET Actual shortage 2024-08-30 2025-04-21 236418
NAT-LEVETIRACETAM 250MG TABLET Resolved 2019-02-15 2022-07-01 75810
NAT-LEVETIRACETAM 500MG TABLET Resolved 2018-10-19 2020-10-26 64878
NAT-LEVETIRACETAM 750MG TABLET Resolved 2019-04-17 2021-10-15 81921
NAT-LEVETIRACETAM 750MG TABLET Actual shortage 2025-04-04 2025-04-09 254205
NAT-MONTELUKAST 5MG TABLET (CHEWABLE) Actual shortage 2024-04-29 2025-01-02 226582
NAT-MONTELUKAST 4MG TABLET (CHEWABLE) Actual shortage 2024-04-29 2025-01-02 226579
NAT-OMEPRAZOLE DR 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-06-13 2025-04-08 230400
NAT-ONDANSETRON 4MG TABLET Actual shortage 2024-06-13 2024-07-02 230407
NAT-PREGABALIN 225MG CAPSULE Actual shortage 2023-05-17 2024-11-01 192650
NAT-QUETIAPINE 300MG TABLET Resolved 2019-04-17 2022-07-01 81906
NAT-QUETIAPINE 25MG TABLET Resolved 2018-10-31 2022-07-01 65944
NAT-QUETIAPINE 100MG TABLET Resolved 2019-04-17 2022-07-01 81900
NAT-QUETIAPINE 150MG TABLET Resolved 2019-04-23 2021-10-31 82236

Showing 21 to 40 of 49

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0